Study of Tumor and Blood Samples From Women With Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT00897728
- Lead Sponsor
- Institut Curie
- Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tumor and blood samples from women with breast cancer.
- Detailed Description
OBJECTIVES:
Primary
* Assess relapse locally or remotely using biomarkers collected from primary tumor and blood samples from women with breast cancer during the first 2 years after diagnosis.
Secondary
* Evaluate all relapses.
* Assess survival without relapse.
* Determine correlation between biomarkers and relapse.
OUTLINE: Primary tumor and blood samples collected during usual care of patients during the first 2 years after diagnosis are analyzed for biomarkers useful in monitoring and diagnosing breast cancer.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 180
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Institut Curie Hopital
🇫🇷Paris, France
Institut Curie Hopital🇫🇷Paris, FrancePaul-Henri CottuContact33-3-8393-5005